학술논문
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)
Document Type
Article
Author
Lam, L.L.; Sjoquist, K.M.; Martin, A.J.; Yip, S.; Hague, W.; Gebski, V.; Jaworski, A.; Simes, J.; Pavlakis, N.; Shitara, K.; Kang, Y.-K.; Bang, Y.-J.; Lee, K.-W.; Chen, L.-T.; Moehler, M.; Bekaii-Saab, T.; Alcindor, T.; O’Callaghan, C.J.; Tebbutt, N.C.; Chan, H.; Rha, S.Y.; Zalcberg, J.; Price, T.; Goldstein, D.
Source
In: BMC Cancer . (BMC Cancer, December 2023, 23(1))
Subject
Language
English
ISSN
14712407